News
Head and neck cancer research project granted
Professor Malin Lindstedt obtained a new grant from The Swedish cancer society (Cancerfonden) for a project focused on the function and prognostic impact of myeloid cells in the tumor microenvironment of Head and Neck cancer (2 400 000 SEK).
Immunotechnology staff member chair committee in collaboration with the nomenclature subcommittee of the IUIS
The nomenclature subcommittee on immunoglobulin, T cell receptor and MHC of the International Union of Immunological Societies (IUIS) has been restructured.
New grant enables installation of a state-of-the-art flow cytometer at the department infrastructure
Associate Professor Kristina Lundberg has received a grant (1.5 mil SEK) from Ingabritt and Arne Lundbergs foundation for purchasing a multiparameter flow cytometer with capacity to sort cells.
Tool for valid analysis of antibody responses in mice
Finally there is a resource to enable proper sequence analysis of antibody responses in the commonly used Balb/c mouse strain.
A novel, antibody-based radiopharmaceutical for advanced thyroid cancer
In collaboration with Assoc. Prof Marika Nestor (Uppsala University) the facilities of SciLifeLab's Drug Discovery and Development Platform, including the Human Antibody Therapeutics unit at the Dept. of Immunotechnology, have co-developed an antibody-based radiopharmaceutical intended for treatment of advanced thyroid cancer. The project now exits [...]
Strategic research activity at Alligator Bioscience AB
Professor Malin Lindstedt has received a Strategic Mobility Grant (1.24 MSEK) from the Swedish Foundation for Strategic Research. She will work part-time at Alligator Bioscience AB in Lund during 2022-2023 within the field of cancer immunotherapies.
Strategic research activity at Alligator Bioscience AB
Professor Malin Lindstedt has received a Strategic Mobility Grant (1.24 MSEK) from the Swedish Foundation for Strategic Research. She will work part-time at Alligator Bioscience AB in Lund during 2022-2023 within the field of cancer immunotherapies.
The Swedish Research Council funds protein PTM research at the Dept. of Immunotechnology
Associate Professor (Docent) Magnus Jakobsson from the Dept. of Immunotechnology today received a grant of 4.0 MSEK from the Swedish Research Council to fund exploratory research on protein regulation through so-called post-translational modification (PTM) in human health and disease.
The Swedish Research Council funds protein PTM research at the Dept. of Immunotechnology
Associate Professor (Docent) Magnus Jakobsson from the Dept. of Immunotechnology today received a grant of 4.0 MSEK from the Swedish Research Council to fund exploratory research on protein regulation through so-called post-translational modification (PTM) in human health and disease.
Department researcher uncovers orphan PTM
“Cells synthesize proteins from a DNA template and expand their biochemical repertoire through dynamic and enzyme-catalysed post-translational modifications (PTM). Methylation of the amino acid histidine was first reported in the late 1960s but until recently very little was known about its enzymology, extent and function.